Loading emails...
Dana-Farber Emails
RAS Inhibitor Offers Pancreatic Cancer Survivors Renewed Hope Fundraising Appeal
9/17/2026Dana-Farber Research News 9-15-2026Newsletter/Update
9/15/2026FDA Approves First-of-Its-Kind Treatment for Pancreatic CancerEvent Invitation
9/3/2026Dana-Farber Research News 9-1-2026Newsletter/Update
9/1/2026GLP-1 Medications and Cancer: What We Know So FarRe-engagement
8/27/2026Dana-Farber Research Drives New Ovarian Cancer Clinical TrialFundraising Appeal
8/20/2026Dana-Farber Research News 8-15-2026Newsletter/Update
8/15/2026Could Peptides Increase Cancer Risk? What You Need to KnowRe-engagement
8/6/2026Dana-Farber Research News 8-1-2026Newsletter/Update
8/1/2026Patient Continues to Lead a Creative Life After Rare CancerNewsletter/Update
7/30/2026Want to see more?
Create a free account to browse all 42 emails from Dana-Farber with full content access.